Stock BLAU3 BLAU FARMACÊUTICA S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Blau Farmacêutica S.A.

Equities

BLAU3

BRBLAUACNOR8

Market Closed - Sao Paulo
Other stock markets
 04:06:01 2024-06-20 pm EDT 		5-day change 1st Jan Change
9.41 BRL -8.96% Intraday chart for Blau Farmacêutica S.A. -6.74% -42.66%
May. 08 Transcript : Blau Farmacêutica S.A., Q1 2024 Earnings Call, May 08, 2024
May. 07 Blau Farmacêutica S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Blau Farmacêutica S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Blau Farmacêutica S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Blau Farmacêutica S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Tranche Update on Blau Farmacêutica S.A.'s Equity Buyback Plan announced on June 14, 2022.
CI
Blau Farmacêutica S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Blau Farmacêutica S.A. completed the acquisition of Laboratorio Quimico Farmaceutico Bergamo Ltda from Amgen Inc. for $33.2 million.
CI
Tranche Update on Blau Farmacêutica S.A.'s Equity Buyback Plan announced on June 14, 2022.
CI
Blau Farmacêutica S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Tranche Update on Blau Farmacêutica S.A.'s Equity Buyback Plan announced on June 14, 2022.
CI
Blau Farmacêutica S.A. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Tranche Update on Blau Farmacêutica S.A.'s Equity Buyback Plan announced on June 14, 2022.
CI
Blau Farmacêutica S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Blau Farmacêutica S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Blau Farmacêutica S.A. announces an Equity Buyback for 4,484,848 shares, representing 2.5% of its issued share capital.
CI
Blau Farmacêutica S.A. authorizes a Buyback Plan.
CI
Blau Farmacêutica S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Blau Farmacêutica S.A. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Brazilian companies hear the siren's call of U.S. stock exchanges
RE
Blau Farmac?utica S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Blau Farmacêutica S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BLAU3 Stock
  4. News Blau Farmacêutica S.A.
  5. Highlights